Rafat Ansari
Medical Oncology · Mishawaka, INNPI 1013911593
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by GSK at 41.9% of the total. Reporting peaked in 2020 at $28,276 and has fallen 99.0% since, to $281 in 2025. Among medical oncology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $1010.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$38K
- AstraZeneca$12K
- Johnson & Johnson$9K
- Epizyme, Inc.$8K
- Jazz Pharmaceuticals Inc.$5K
- Tesaro, Inc.$5K
- plus $13K from 20 others
What the payments were for
- Consulting fees$30,75334%
- Speaking & faculty fees$52,93559%
- Travel & lodging$3,0193%
- Food & beverage$3,1734%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 18 | $37,670 |
| AstraZeneca | 8 | $11,805 |
| Johnson & Johnson | 11 | $9,288 |
| Epizyme, Inc. | 10 | $7,675 |
| Jazz Pharmaceuticals Inc. | 7 | $5,490 |
| Tesaro, Inc. | 4 | $4,913 |
| Merck | 4 | $3,846 |
| Beigene USA, Inc. | 1 | $1,875 |
| Bristol Myers Squibb | 1 | $1,650 |
| Karyopharm Therapeutics Inc. | 1 | $1,500 |
| Athenex Pharmaceutical Division, LLC | 1 | $1,250 |
| Rigel Pharmaceuticals, Inc. | 1 | $1,200 |
| Puma Biotechnology, Inc. | 2 | $249 |
| Pfizer | 2 | $248 |
| Lilly USA, LLC | 4 | $178 |
| Amgen | 2 | $155 |
| Regeneron Healthcare Solutions, Inc. | 2 | $143 |
| Tempus AI, Inc | 1 | $133 |
| Sanofi | 1 | $125 |
| Novartis | 1 | $125 |
| EMD Serono, Inc. | 1 | $125 |
| Genentech USA, Inc. | 2 | $114 |
| Bayer | 1 | $108 |
| AbbVie | 1 | $15 |
| Gilead | 1 | $12 |
| Clovis Oncology, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$89,894 in reported general payments places this provider in the 95th percentile of 67 medical oncology providers in Indiana.
Other medical oncology in Mishawaka
- Robin ZonMishawaka$12K
- Bilal AnsariMishawaka$9K
- Rashid KhanMishawaka$6K
- Rolan PascualMishawaka$4K
- Jose BufillMishawaka$3K
- Sayuri CheruvuMishawaka$2K
- Costantine AlbanyLafayette$212K
- Sunil BabuFort Wayne$166K
- Natraj AmmakkanavarIndianapolis$129K
- Bert OneilIndianapolis$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.